IL133093A0 - 5-(2-Ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine maleate - Google Patents

5-(2-Ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine maleate

Info

Publication number
IL133093A0
IL133093A0 IL13309398A IL13309398A IL133093A0 IL 133093 A0 IL133093 A0 IL 133093A0 IL 13309398 A IL13309398 A IL 13309398A IL 13309398 A IL13309398 A IL 13309398A IL 133093 A0 IL133093 A0 IL 133093A0
Authority
IL
Israel
Prior art keywords
tetrazol
ethyl
methyl
tetrahydropyridine
maleate
Prior art date
Application number
IL13309398A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of IL133093A0 publication Critical patent/IL133093A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13309398A 1997-07-01 1998-07-01 5-(2-Ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine maleate IL133093A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK78197 1997-07-01
PCT/DK1998/000294 WO1999001448A1 (fr) 1997-07-01 1998-07-01 Maleate de 5-(2-ethyl-2h-tetrazole-5-yl)-1-methyle-1,2,3,6-tetrahydropyridine

Publications (1)

Publication Number Publication Date
IL133093A0 true IL133093A0 (en) 2001-03-19

Family

ID=8097489

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13309398A IL133093A0 (en) 1997-07-01 1998-07-01 5-(2-Ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine maleate

Country Status (25)

Country Link
EP (1) EP0994869A1 (fr)
JP (1) JP2002507215A (fr)
KR (1) KR20010014297A (fr)
CN (1) CN1261361A (fr)
AR (1) AR013096A1 (fr)
AU (1) AU735751B2 (fr)
BG (1) BG103933A (fr)
BR (1) BR9810331A (fr)
CA (1) CA2293324A1 (fr)
CO (1) CO4940483A1 (fr)
EA (1) EA200000081A1 (fr)
HU (1) HUP0002876A2 (fr)
IL (1) IL133093A0 (fr)
IS (1) IS5278A (fr)
JO (1) JO2031B1 (fr)
MA (1) MA25138A1 (fr)
NO (1) NO996580L (fr)
PE (1) PE116099A1 (fr)
PL (1) PL337184A1 (fr)
SK (1) SK187399A3 (fr)
TN (1) TNSN98120A1 (fr)
TR (1) TR199903283T2 (fr)
UY (2) UY25069A1 (fr)
WO (1) WO1999001448A1 (fr)
ZA (1) ZA985498B (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
TR199800801T2 (xx) * 1995-11-06 1998-08-21 H. Lund-Beck A/S Travmatik beyin yaralanmalar�n�n tedavisi.

Also Published As

Publication number Publication date
PE116099A1 (es) 1999-11-23
JP2002507215A (ja) 2002-03-05
CO4940483A1 (es) 2000-07-24
BG103933A (en) 2000-07-31
CA2293324A1 (fr) 1999-01-14
IS5278A (is) 1999-11-30
AR013096A1 (es) 2000-12-13
SK187399A3 (en) 2000-06-12
NO996580D0 (no) 1999-12-30
HUP0002876A2 (hu) 2001-06-28
CN1261361A (zh) 2000-07-26
TR199903283T2 (xx) 2000-06-21
AU735751B2 (en) 2001-07-12
AU8102098A (en) 1999-01-25
NO996580L (no) 1999-12-30
JO2031B1 (en) 1999-05-15
BR9810331A (pt) 2000-09-05
MA25138A1 (fr) 2001-04-02
PL337184A1 (en) 2000-08-14
EP0994869A1 (fr) 2000-04-26
UY25069A1 (es) 1998-12-21
WO1999001448A1 (fr) 1999-01-14
UY25177A1 (es) 2000-12-29
EA200000081A1 (ru) 2000-08-28
ZA985498B (en) 1999-01-20
KR20010014297A (ko) 2001-02-26
TNSN98120A1 (fr) 2005-03-15

Similar Documents

Publication Publication Date Title
IL136267A0 (en) 1,3,4-THIADIZOLES AND 1,3,4-OXADIAZOLES AS αVβ3 ANTAGONISTS
GC0000108A (en) 4-Amino substituted-2-substituted-1,2,3,4-tetrahy droquinolines.
DE69941083D1 (en) 12,13-cyclopropan-epothilonderivate
AU2957997A (en) 1,2,4-oxadiazoles as adhesion-receptor antagonists
MXPA02001088A (es) 2-pirazolin-5-onas..
ZA97303B (en) Pyrido-fused thienyl- and furanyl-oxazolidinones
HU9501077D0 (en) 3,5-disubstituted tetrahydrofuran-2-one
ZA976224B (en) 4-hydroxy-piperidine derivatives.
HUP9904622A3 (en) 1,4-di-sustituted piperidines as muscarinic antagonists
PL339350A1 (en) 3-(1,2-benzothiazole- or isoxazo-5-yl)-substituted pyrimidines as herbicides
ZA985875B (en) Azetidines.
ZA987304B (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives.
IL133679A0 (en) Receptor kinase, bin 1
GB2325667B (en) Triazine derivatives containing 2,2,6,6-tetramethyl-4-piperidyl groups
IL138220A0 (en) 3',3',-n-bis substituted macrolide lhrh antagonists
IL149507A0 (en) 3-(4,5-dihydroisoxazole-5-yl) benzoylpyrazole
PL343378A1 (en) Paroxetine maleate
IL133093A0 (en) 5-(2-Ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine maleate
AU6827300A (en) Substituted arylalkylamino-1,3,5-triazines
ZA979781B (en) Piperidine derivatives.
HUP9902810A3 (en) 1,4-dihydropyridine compounds as bradykinin antagonists
HUP0204169A3 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines an
ZA981529B (en) Substituted 2,4-diaminopyrimidine
GB2337048B (en) 2,1,3-Benzothiadiazole containing endothelin antagonists
ZA99626B (en) "A-Lock".